Pharmaceutical Industry Veteran and Pioneer Sidney Taurel Joins ...
Capital Royalty Promotes Mike Weinmann to Managing Director
Capital Royalty Strengthens Royalty Investment Team With Three New ...
Capital Royalty Enhances Royalty Investment Team With New Principals ...
Nathan Hukill Joins Capital Royalty as Managing Director
News
Capital Royalty Purchases Interest in Royalty Portfolio
In the fourth quarter of 2009, a global pharmaceutical company sold a royalty interest in two leading drugs targeting different therapeutic areas to a consortium of investors (including Capital Royalty) for more than $100 million.
The Evolution of Healthcare Royalty Monetization
Since they first appeared in the early 1990s, royalty monetization transactions have grown in both size and complexity. This evolution reflects the willingness of investors to work collaboratively with royalty recipients to develop creative structures that address the nuances of a particular situation and/or the desired risk profiles of either party.